Search - tctmd.com

Displaying 261 - 280 of 1180

Sort: Relevancy | Date

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Daily News

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Michael O'Riordan

June 06, 2016

News Daily News

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Todd Neale

May 27, 2016

News Daily News

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

Caitlin E. Cox

May 26, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Caitlin E. Cox

May 26, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

News Daily News

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

Michael O'Riordan

March 31, 2016

News Daily News

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Yael L. Maxwell

March 30, 2016

News Daily News

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Yael L. Maxwell

March 30, 2016

News Daily News

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

Michael O'Riordan

March 30, 2016

News Daily News

IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era

Todd Neale

March 22, 2016

News Daily News

En China la Incidencia de la EAC es Cada Vez Mayor y los Índices de Cateterización y PCI Empiezan a Subir

Leah Lawrence

March 18, 2016

News Daily News

Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount

Leah Lawrence

March 18, 2016

News Daily News

Un Panel de la FDA Avala por Mayoría Aplastante el Stent Bioabsorbible Absorb

Michael O'Riordan

March 16, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

新一代 DES 对复杂 CAD 效果更好，为 CABG 比较铺平了道路

Todd Neale

March 15, 2016

Advertisement

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

New European Device Regulations Are Coming, Could Impact Speed of Approvals

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era

En China la Incidencia de la EAC es Cada Vez Mayor y los Índices de Cateterización y PCI Empiezan a Subir

Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount

Un Panel de la FDA Avala por Mayoría Aplastante el Stent Bioabsorbible Absorb

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

新一代 DES 对复杂 CAD 效果更好，为 CABG 比较铺平了道路

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content